Model
Edge
PharmaCyte Biotech Inc.
PMCB
Filing Type
8-K
Filing Date
9/4/2025
Updated
9/5/25, 2:05 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Completing Asset Acquisition or Sale, Reg. FD
EX-10.1
SECURITIES PURCHASE AGREEMENT, DATED SEPTEMBER 2, 2025
EX-10.2
FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES H CONVERTIBLE PREFERRED STOCK OF TNF PHARMACEUTICALS, INC.
EX-10.3
FORM OF WARRANT OF TNF PHARMACEUTICALS, INC
EX-10.4
REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 2, 2025
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Reg. FD